跳至主要内容
临床试验/NCT04563793
NCT04563793已完成不适用

Postmarket Outcomes Study for Evaluation of the Superion™ Spacer

Boston Scientific Corporation23 个研究点 分布在 1 个国家目标入组 129 人开始时间: 2020年10月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
129
试验地点
23
主要终点
Low Back Pain Responder Rate

研究概览

简要总结

To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

详细描述

The purpose of this outcomes study is to compile real-world outcomes for the commercially approved Indirect Decompression Systems (IDS) in routine clinical practice when used according to the applicable Instructions for Use.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled to receive or previously received a commercially approved Boston Scientific Indirect Decompression Systems, per local Instructions for Use (IFU)
  • Signed a valid, IRB approved informed consent form

排除标准

  • Meets any contraindication in BSC Indirect Decompression Systems local IFU

结局指标

主要结局

Low Back Pain Responder Rate

时间窗: Up to 3 years post-procedure

Proportion of subjects with an improvement of 20 mm during the last 7 days for low back pain at 6 months, 1 year, 2 years, and 3 years post-procedure compared with Baseline (VAS)

Left Leg Pain Responder Rate

时间窗: Up to 3 years post-procedure

Proportion of subjects with an improvement of 20 mm during the last 7 days for left leg pain at 6 months, 1 year, 2 years, and 3 years post-procedure compared with Baseline (VAS)

Right Leg Pain Responder Rate

时间窗: Up to 3 years post-procedure

Proportion of subjects with an improvement of 20 mm during last 7 days for left leg pain at 6 months, 1 year, 2 years, and 3 years post-procedure compared with Baseline (VAS)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (23)

Loading locations...

相似试验